09/03/2021 - Campus Can Ruti, Projects, Research

The start of a new international clinical trial to improve treatment for tuberculosis with anti-inflammatory agents

The Experimental Tuberculosis Group at the IGTP has set up this trial, coordinated from Can Ruti, within the European project H2020 ‘SMA-TB’. The study will evaluate the efficacy and safety of adding acetylsalicylic acid or ibuprofen to the antibiotic treatments applied for tuberculosis. It is a phase II trial which will be carried out in South Africa and Georgia, two of the countries the WHO has in its sights to control this infectious disease. The trial has been prepared in the midst of the pandemic, with the added challenge of coordinating it with the restrictions and different stages of the epidemic in each of the countries involved.

13/01/2021 - Campus Can Ruti, Projects

8 health professionals from Germans Trias awarded Talents grants

The Talents Programme supports research projects in the health sector and despite the pandemic research into other diseases continues. 14 health professionals in all, and 8 of them from Germans Trias i Pujol, have been awarded grants to carry out research projects in the 2020 edition of the programme. The awards represent recognition for young health professionals who are carrying out research activities.

19/10/2020 - Projects, Research

Germans Trias joins the International study on using the BCG vaccine against COVID-19 in healthcare workers

The Can Ruti Campus joins an ambitious international study to test the possible protective effects of the anti-tuberculosis (BCG) vaccine against COVID-19. In Spain the provision is for 1,000 healthcare workers to take part. The Germans Trias i Pujol Hospital and Research Institute is taking part with Dr Antoni Rosell, Clinical Director of the Thorax Department at the hospital leading the project and the participation of the Pulmonology, Preventive Medicine and Pharmacy together with two research groups working on tuberculosis at the IGTP led by Dr Pere-Joan Cardona and Dr José Domínguez.

05/08/2020 - Projects, Research

Full marks for the mid-term meeting of the European Project INNOVA4TB coordinated from the IGTP

At the start of Julio the mid-tem meeting of the European project "Innovation in Tuberculosis-INNOVA4TB", designed and coordinated by the Innovation in Respiratory Infections and Tuberculosis Diagnosis research group led by Dr José Dominguez and Cristina Prat took place. INNOVA4TB is a European Project focused on the diagnosis and clinical handling of tuberculosis financed by a Marie Skłodowska Curie award.

17/06/2020 - Projects, Research

A world consortium to study the genetic factors associated with COVID-19

COVID-19 has caused a global pandemic and this in turn has accelerated the formation of international collaborations more than ever, although they are already common in biomedical research. The COVID-19 Host Genetics Initiative was formed to share knowledge and data to study the role of genetic factors in susceptibility to infection by SARS-CoV-2 and severity of the disease. The GCAT-Genomes for Life Project at the IGTP is taking part. The methodology has been described in a paper in the European Journal of Human Genetics.

07/04/2020 - Campus Can Ruti, Projects, Research

Two projects at the IGTP and IDIAP Jordi Gol research centres focus on the immune response of health professionals to infection with SARS-CoV-2

The IGTP has received funding in the extraordinary call published by the Department of Research and Innovation of the Department of Health (DGRIS) with the collaboration of AQuAS and Biocat and aimed at all the Iriscat centres for research into coronavirus. The two projects, focussed on the immune response of health professionals on the frontline with the virus, have joined the forces of the IGTP, IrsiCaixa and research and healthcare in the context of primary and hospital healthcare. A third project, led by Dr Julià Blanco, researcher at IrsiCaixa and the IGTP has also received funding.

27/03/2020 - Campus Can Ruti, Institutional, Projects

The IGTP is working to respond to COVID-19

The Germans Trias I Pujol Research Institute (IGTP) is working alongside the hospital and at the service of the Ministry of Health of the Government of Catalonia to make all the necessary disposable material and resources available for the diagnosis and treatment of COVID-19. The research groups at the centre are also working against the clock to prepare projects for the extraordinary competitive funding calls that have been issued to fund research into SARS-CoV-2 and the disease COVID-19.

19/03/2020 - Projects, Research

Researchers at the UPC and the IGTP use mathematical models to evaluate the evolution of the COVID-19 epidemic and the effectiveness of the control measures

A team of researchers from the Computational Biology and Complex Systems research group (BIOCOM-SC) of the UPC and the Centre for Comparative Medicine and Bioimage (CMCiB) of the Germans Trias i Pujol Research Institute (IGTP) with the support of "la Caixa" Foundation, have developed a mathematical model to follow up the epidemic of COVID-19. The report that they have produced for the Strategy Office of the European Union is updated every day and includes predictions for Catalonia, Spain and the European Union. The model also serves to analyze the efficiency of the measures being established by different countries

31/10/2019 - Institutional, Projects, Research

The “La Marató de TV3” Foundation funds three cancer Research projects at Germans Trias

Yesterday evening the ceremony to present awards to the 43 projects that will receive funding for cancer research from the 2018 edition of the La Marató de TV3 and Catalunya Radio was held at the Academy of Medical Sciences. Three of the projects will be carried out under the leadership of Germans Trias professionals.

25/09/2019 - Projects, Research

Synchrotron light for deciphering Friedreich's ataxia

The Neurogenetics research group, led by Dr Antoni Matilla is performing an experiment at the ALBA Synchrotron to obtain for the first time 3D images of cells with this disease. Friedreich's ataxia affects more than 3,000 people in Spain, causing serious mobility problems and other severe illnesses such as heart disease. At present there is no treatment to prevent or cure the disease